These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 60445)

  • 1. Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence Jones proteins.
    Solomon A; Schmidt W; Havemann K
    J Immunol; 1976 Sep; 117(3):1010-4. PubMed ID: 60445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic cleavage of human IgG molecules by neutral proteases of polymorphonuclear leukocytes.
    Solomon A; Gramse M; Havemann K
    Eur J Immunol; 1978 Nov; 8(11):782-5. PubMed ID: 102513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bence Jones proteins and light chains of immunoglobulins. XI. A transient Bence Jones-related protein associated with corticosteroid therapy.
    Solomon A; McLaughlin CL; Capra JD
    J Clin Invest; 1975 Mar; 55(3):579-86. PubMed ID: 803979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel human light chain V kappa segment: serologic and structural analyses of the kappa III-like Bence Jones protein and IgG kappa light chain REE.
    Prelli F; Tummolo D; Solomon A; Frangione B
    J Immunol; 1986 Jun; 136(11):4169-73. PubMed ID: 2422275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of neutral proteases from blood leukocytes on human platelets.
    Bykowska K; Kaczanowska J; Karpowicz M; Stachurska J; Kopeć M
    Thromb Haemost; 1983 Dec; 50(4):768-72. PubMed ID: 6320486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical study of a human myeloma IgG1 half molecule.
    Seligmann M; Mihaesco E; Chevalier A; Miglierina R
    Ann Immunol (Paris); 1978; 129 C(6):855-70. PubMed ID: 85430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neutral proteases from human leukocytes on structure and biological properties of human factor VIII.
    Kopeć M; Bykowska K; Lopaciuk S; Jelenska M; Kaczanowska J; Sopata I; Wojtecka E
    Thromb Haemost; 1980 Jul; 43(3):211-7. PubMed ID: 6256922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The primary structure of a monoclonic immunoglobulin-L-chain of subgroup IV of the kappa type (Bence-Jones protein Len.)].
    Schneider M; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1975 May; 356(5):507-57. PubMed ID: 50995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bence Jones proteins and light chains of immunoglobulins. XIV. Conformational dependency and molecular localization of the kappa (kappa) and lambda (lambda) antigenic determinants.
    Solomon A
    Scand J Immunol; 1976; 5(6-7):685-95. PubMed ID: 62385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global fluctuations of the immunoglobulin domains under physiological conditions.
    Kawata Y; Hamaguchi K
    Biopolymers; 1990; 30(3-4):389-94. PubMed ID: 2126211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of human lambda light chain V/J/C segments: serologic analysis and primary structure of the lambda VI Bence Jones protein THO.
    Ghiso J; Solomon A; Frangione B
    J Immunol; 1986 Jan; 136(2):716-9. PubMed ID: 3079791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.
    Gramse M; Bingenheimer C; Schmidt W; Egbring R; Havemann K
    J Clin Invest; 1978 Apr; 61(4):1027-33. PubMed ID: 77863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic and antigenic epitopes of immunoglobulins. XVIII. Subpopulations of human lambda chains defined with a panel of monoclonal antibodies.
    Walker MR; Solomon A; Ling NR; Brown B; Lowe JA; Hardie D; Jefferis R
    Immunology; 1986 Nov; 59(3):467-71. PubMed ID: 2432000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ionization and reactivities of the thiol groups which participate in the formation of interchain disulfide bonds of Bence Jones proteins and an Fab(t) fragment.
    Tanaka Y; Azuma T; Hamaguchi K
    J Biochem; 1978 May; 83(5):2149-63. PubMed ID: 566268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxic potential of Bence Jones proteins.
    Solomon A; Weiss DT; Kattine AA
    N Engl J Med; 1991 Jun; 324(26):1845-51. PubMed ID: 1904132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts of the formation and composition of amyloid.
    Glenner GG
    Ann Clin Lab Sci; 1975; 5(4):257-63. PubMed ID: 808999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
    Solomon A; Weiss DT; Macy SD; Antonucci RA
    Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and VL fragment.
    Paul S; Li L; Kalaga R; Wilkins-Stevens P; Stevens FJ; Solomon A
    J Biol Chem; 1995 Jun; 270(25):15257-61. PubMed ID: 7797511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bence Jones proteins and light chains of immunoglobulins. II. Immunochemical differentiation and classification of kappa-chains.
    Solomon A; McLaughlin CL
    J Exp Med; 1969 Dec; 130(6):1295-311. PubMed ID: 4187526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.